(Q38240972)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25134468%20AND%20SRC:MED&resulttype=core&format=json

12 March 2020

title

Human stem cell-derived cardiomyocytes in cellular impedance assays: bringing cardiotoxicity screening to the front line (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25134468%20AND%20SRC:MED&resulttype=core&format=json

12 March 2020

0 references

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25134468%20AND%20SRC:MED&resulttype=core&format=json

12 March 2020

author name string

Matthew F Peters

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25134468%20AND%20SRC:MED&resulttype=core&format=json

12 March 2020

Sarah D Lamore

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25134468%20AND%20SRC:MED&resulttype=core&format=json

12 March 2020

Liang Guo

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25134468%20AND%20SRC:MED&resulttype=core&format=json

12 March 2020

Clay W Scott

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25134468%20AND%20SRC:MED&resulttype=core&format=json

12 March 2020

publication date

1 April 2015

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25134468%20AND%20SRC:MED&resulttype=core&format=json

Cardiovascular Toxicology

12 March 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25134468%20AND%20SRC:MED&resulttype=core&format=json

12 March 2020

volume

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25134468%20AND%20SRC:MED&resulttype=core&format=json

12 March 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25134468%20AND%20SRC:MED&resulttype=core&format=json

12 March 2020

page(s)

127-139

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25134468%20AND%20SRC:MED&resulttype=core&format=json

Can pharmacogenetics help rescue drugs withdrawn from the market?

12 March 2020

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS12012-014-9268-9

Enhanced selectivity screening of GPCR ligands using a label-free cell based assay technology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12012-014-9268-9

The future of drug safety testing: expanding the view and narrowing the focus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12012-014-9268-9

Cellular dielectric spectroscopy: a powerful new approach to label-free cellular analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12012-014-9268-9

Micromotion of mammalian cells measured electrically

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12012-014-9268-9

Label-free whole-cell assays: expanding the scope of GPCR screening

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12012-014-9268-9

Functional cardiotoxicity profiling and screening using the xCELLigence RTCA Cardio System

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12012-014-9268-9

Dynamic monitoring of beating periodicity of stem cell-derived cardiomyocytes as a predictive tool for preclinical safety assessment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12012-014-9268-9

Estimating the risk of drug-induced proarrhythmia using human induced pluripotent stem cell-derived cardiomyocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12012-014-9268-9

Cell adhesion: integrating cytoskeletal dynamics and cellular tension

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12012-014-9268-9

Absence of transverse tubules contributes to non-uniform Ca(2+) wavefronts in mouse and human embryonic stem cell-derived cardiomyocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12012-014-9268-9

Molecular characterization and functional properties of cardiomyocytes derived from human inducible pluripotent stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12012-014-9268-9

Regulation of systolic [Ca2+]i and cellular Ca2+ flux balance in rat ventricular myocytes by SR Ca2+, L-type Ca2+ current and diastolic [Ca2+]i

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12012-014-9268-9

Model of excitation-contraction coupling of rat neonatal ventricular myocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12012-014-9268-9

Evaluation of cellular impedance measures of cardiomyocyte cultures for drug screening applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12012-014-9268-9

Cell death assays for drug discovery

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12012-014-9268-9

Cellular impedance assays for predictive preclinical drug screening of kinase inhibitor cardiovascular toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12012-014-9268-9

Multiparameter in vitro assessment of compound effects on cardiomyocyte physiology using iPSC cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12012-014-9268-9

Balancing drug risk and benefit: toward refining the process of FDA decisions affecting patient care

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12012-014-9268-9

Relationships between preclinical cardiac electrophysiology, clinical QT interval prolongation and torsade de pointes for a broad range of drugs: evidence for a provisional safety margin in drug development

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12012-014-9268-9

Refining the human iPSC-cardiomyocyte arrhythmic risk assessment model

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12012-014-9268-9

An evaluation of hERG current assay performance: Translating preclinical safety studies to clinical QT prolongation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12012-014-9268-9

Rechanneling the cardiac proarrhythmia safety paradigm: a meeting report from the Cardiac Safety Research Consortium

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12012-014-9268-9

Impedance-based detection of beating rhythm and proarrhythmic effects of compounds on stem cell-derived cardiomyocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12012-014-9268-9

In vitro model for assessing arrhythmogenic properties of drugs based on high-resolution impedance measurements.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12012-014-9268-9

Cardiotoxicity associated with targeting kinase pathways in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12012-014-9268-9

Validation of an in vitro contractility assay using canine ventricular myocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12012-014-9268-9

Cardiotoxicity of kinase inhibitors: the prediction and translation of preclinical models to clinical outcomes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12012-014-9268-9

Multi-parameter in vitro toxicity testing of crizotinib, sunitinib, erlotinib, and nilotinib in human cardiomyocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12012-014-9268-9

Use of human stem cell derived cardiomyocytes to examine sunitinib mediated cardiotoxicity and electrophysiological alterations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12012-014-9268-9

Comprehensive assay of kinase catalytic activity reveals features of kinase inhibitor selectivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12012-014-9268-9

Comprehensive analysis of kinase inhibitor selectivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12012-014-9268-9

Phenotypic screening with human iPS cell-derived cardiomyocytes: HTS-compatible assays for interrogating cardiac hypertrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12012-014-9268-9

Surface:volume relationship in cardiac myocytes studied with confocal microscopy and membrane capacitance measurements: species-dependence and developmental effects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12012-014-9268-9

Controlling the contractile strength of engineered cardiac muscle by hierarchal tissue architecture

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12012-014-9268-9

Cardiomyocytes derived from human induced pluripotent stem cells as models for normal and diseased cardiac electrophysiology and contractility

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12012-014-9268-9

How can we improve our understanding of cardiovascular safety liabilities to develop safer medicines?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12012-014-9268-9

Drug screening using a library of human induced pluripotent stem cell-derived cardiomyocytes reveals disease-specific patterns of cardiotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12012-014-9268-9

Comparison of electrophysiological data from human-induced pluripotent stem cell-derived cardiomyocytes to functional preclinical safety assays

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12012-014-9268-9

Screening drug-induced arrhythmia [corrected] using human induced pluripotent stem cell-derived cardiomyocytes and low-impedance microelectrode arrays

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12012-014-9268-9

Assessment of beating parameters in human induced pluripotent stem cells enables quantitative in vitro screening for cardiotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12012-014-9268-9

High throughput measurement of Ca²⁺ dynamics for drug risk assessment in human stem cell-derived cardiomyocytes by kinetic image cytometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12012-014-9268-9

Biohybrid thin films for measuring contractility in engineered cardiovascular muscle.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12012-014-9268-9

Phenotypic profiling of structural cardiotoxins in vitro reveals dependency on multiple mechanisms of toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12012-014-9268-9

Cardiac excitation-contraction coupling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12012-014-9268-9

Human induced pluripotent stem cells and their use in drug discovery for toxicity testing

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12012-014-9268-9

10.1007/S12012-014-9268-9

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25134468%20AND%20SRC:MED&resulttype=core&format=json

Dimensions Publication ID

12 March 2020

1017261624

0 references

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25134468%20AND%20SRC:MED&resulttype=core&format=json